tiotropium/olodaterol

DRUG2 trials

Sponsors

Boehringer Ingelheim, Yonsei University

Conditions

Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic Obstructive

Unknown Phase

Early Intervention Efficacy in COPD

CompletedNCT04249310

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2020-03-27End: 2020-08-12Updated: 2022-06-14

Effects of Tiotropium/Olodaterol on Cardio-pulmonary Exercise Capacity in Patients With Hyperinflated Chronic Obstructive Pulmonary Disease [ACHIEVE]

CompletedNCT04994574

Yonsei UniversityChronic Obstructive Pulmonary Disease

Start: 2021-08-23End: 2024-07-25Updated: 2026-04-07